Research Articles

Download PDF (776.3 KB)

TOMOGRAPHY, March 2019, Volume 5, Issue 1:68-76
DOI: 10.18383/j.tom.2018.00037

Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers

Nestor Andres Parra1, Hong Lu1, Jung Choi3, Kenneth Gage3, Julio Pow-Sang4, Robert J. Gillies1, Yoganand Balagurunathan1

Departments of 1Cancer Physiology,3Radiology, and4Urology, H.L. Moffitt Cancer Center, Tampa, FL; and2Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China


Prostate cancer identification and assessment of clinical significance continues to be a challenge. Routine multiparametric magnetic resonance imaging has shown to be useful in assessing disease progression. Although dynamic contrast-enhanced imaging (DCE) has the ability to characterize perfusion across time and has shown enormous utility, radiological assessment (Prostate Imaging-Reporting and Data System or PIRADS version 2) has limited its use owing to lack of consistency and nonquantitative nature. In our work, we propose a systematic methodology to quantify perfusion dynamics for the DCE imaging. Using these metrics, 7 different subregions or perfusion habitats of the targeted lesions are localized and related to clinical significance. We found that quantitative features describing the habitat based on the late area under the DCE time-activity curve was a good predictor of clinical significance disease. The best predictive feature in the habitat had an AUC of 0.82, CI [0.81–0.83].

Supplemental Media


Download the article PDF (776.3 KB)

Download the full issue PDF (21.39 MB)

Mobile-ready Flipbook

View the full issue as a flipbook (Desktop and Mobile-ready)